Stefan Graeber Selected Research

Heel Spur (Heel Spurs)

6/2017	Radiotherapy of painful heel spur with two fractionation regimens : Results of a randomized multicenter trial after 48 weeks' follow-up.
8/2015	Randomized multicenter follow-up trial on the effect of radiotherapy on painful heel spur (plantar fasciitis) comparing two fractionation schedules with uniform total dose: first results after three months' follow-up.
1/2015	Randomized multicenter follow-up trial on the effect of radiotherapy for plantar fasciitis (painful heels spur) depending on dose and fractionation - a study protocol.
11/2012	Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12 months' follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Graeber Research Topics

Disease

4	Heel Spur (Heel Spurs) 06/2017 - 11/2012
3	Pain (Aches) 06/2017 - 11/2012
3	Plantar Fasciitis 08/2015 - 11/2012
2	Colorectal Neoplasms (Colorectal Cancer) 03/2012 - 07/2011
2	Chronic Pancreatitis 05/2010 - 01/2008
2	Cystadenoma 05/2010 - 01/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2010 - 01/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Atherosclerosis 03/2016
1	Psychophysiologic Disorders (Psychosomatic Disorders) 01/2015
1	Renal Insufficiency (Renal Failure) 06/2014
1	Stroke (Strokes) 06/2014
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Lung Injury 01/2012
1	Esophageal Neoplasms (Esophageal Cancer) 01/2012
1	Neoplasm Metastasis (Metastasis) 07/2011
1	Bone Resorption 11/2009
1	Osteoporosis 11/2009
1	Eczema 10/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2009
1	Pancreatic Diseases (Pancreatic Disease) 01/2008
1	Neoplasms (Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

3	EnzymesIBA 07/2011 - 01/2008
3	ImmunosorbentsIBA 07/2011 - 01/2008
2	Analgesics (Analgesic Drugs)IBA 08/2015 - 11/2012
2	Interleukin-8 (Interleukin 8)IBA 01/2012 - 01/2008
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	Choline (Choline Chloride)IBA 03/2016
1	trimethyloxamine (trimethylamine N-oxide)IBA 03/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2014
1	LigandsIBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	OsteoprotegerinIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 03/2012
1	Messenger RNA (mRNA)IBA 03/2012
1	3' Untranslated Regions (3' UTR)IBA 03/2012
1	Chemokine CCL20IBA 03/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	CytokinesIBA 01/2012
1	Interleukin-10 (Interleukin 10)IBA 01/2012
1	VitaminsIBA 11/2009
1	OsteocalcinIBA 11/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2009
1	Vitamin B Complex (B Vitamins)IBA 11/2009
1	Tartrate-Resistant Acid PhosphataseIBA 11/2009
1	HomocysteineIBA 11/2009
1	Peptides (Polypeptides)IBA 10/2009
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	Chemotactic FactorsIBA 01/2008
1	ChemokinesIBA 01/2008
1	CXC ChemokinesIBA 01/2008

Therapy/Procedure

4	Radiotherapy 06/2017 - 11/2012
2	Re-Irradiation 06/2017 - 11/2012
1	Therapeutics 01/2015
1	Thoracotomy 01/2012
1	Esophagectomy 01/2012
1	Drug Therapy (Chemotherapy) 07/2011
1	Lasers (Laser) 10/2009